Filter
441
Filtered Results: 441
Text search:
GAVI
Alliance
Featured
Recommendations
40
New Publications
124
Language
Document type
No document type
206
Studies & Reports
107
Strategic & Response Plan
58
Guidelines
29
Manuals
20
Fact sheets
12
Situation Updates
6
Training Material
2
Resource Platforms
1
Countries / Regions
Global
47
Liberia
19
Sierra Leone
16
Kenya
12
Nigeria
10
Africa
10
Nepal
9
Congo, Democratic Republic of
9
Uganda
8
Burkina Faso
7
Guinea
7
Ethiopia
7
Malawi
6
South–East Asia Region
6
Western and Central Europe
6
East and Southern Africa
6
Zambia
6
Myanmar / Burma
6
Ghana
5
Germany
5
Bangladesh
5
Madagascar
5
Syria
4
Senegal
4
Latin America and the Carribbean
4
West and Central Africa
4
Middle East and North Africa
4
Pakistan
4
Benin
3
Cameroon
3
Zimbabwe
3
Cambodia
3
Asia
3
Central African Republic
3
South Sudan
3
India
3
Togo
2
Rwanda
2
Niger
2
Afghanistan
2
Tanzania
2
Eastern Europe and Central Asia
2
South Africa
2
Brazil
2
Namibia
2
Mali
2
Somalia
2
Colombia
1
Ukraine
1
Lesotho
1
China
1
Burundi
1
USA
1
Haiti
1
Japan
1
United Kingdom
1
Eastern Europe
1
Yemen
1
Georgia
1
Botswana
1
Indonesia
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
154
Clinical Guidelines
37
Women & Child Health
31
Public Health
23
Key Resources
10
Pharmacy & Technologies
3
Capacity Building
2
Toolboxes
COVID-19
58
Health Financing Toolbox
45
Rapid Response
28
Global Health Education
25
AMR
22
Ebola
21
Polio
15
Planetary Health
10
Pharmacy
7
HIV
6
NTDs
5
Mental Health
4
TB
4
Cholera
4
Refugee
3
Disability
3
Caregiver
3
NCDs
3
Conflict
3
Health Financing
1
Improving the survival chances and quality of life of women, newborns, and children remains an urgent global challenge. Since 2012, substantial progress has been made in reducing maternal and under-5 deaths, and a only handful of countries are on target to meet the SDG targets in 2030. Yet, 5 millio...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth...
This paper has been prepared to inform discussion at the conference “Beating the DRUM - Domestic Resource Use and Mobilization for accelerating progress towards SDG3,”. Many countries face critical shortfalls in domestic resource use and mobilization (DRUM) for health, threatening to push health...
Financing Global Health 2016: Development Assistance, Public and Private Health Spending for the Pursuit of Universal Health Coverage presents a complete analysis of the resources available for health in 184 countries, with a particular focus on development assistance for health (DAH). DAH was estim...
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass...
The COVID-19 pandemic has resulted in a double shock - health and economic. As of March 1, 2021, COVID-19 has cost more than 2.5 million lives and triggered an economic recession surpassing any economic downturn since World War II.
Part I of this paper explores the impact of this current macro-fisc...
UNAIDS leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. It unites the efforts of 11 UN Cosponsor organizations- UNHCR, UNICEF, WFP, UNDP,UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank- and a Secretari...
The majority of Countdown countries did not reach the fourth Millennium Development Goal (MDG 4) on reducing child mortality, despite the fact that donor funding to the health sector has drastically increased. When tracking aid invested in child survival, previous studies have exclusively focused on...
The Seventy-fifth World Health Assembly through a decision on sustainable financing, adopted the recommendations of the Member States Working Group on Sustainable Financing, contained in Appendix 2 of the Working Group’s report to the Seventy-fifth World Health Assembly. As part of the recommendat...
Development assistance for health (DAH) has grown substantially, totaling more than $31.3 billion in 2013. However, the degree that countries with high concentrations of armed conflict, ethnic violence, inequality, debt, and corruption have received this health aid and how that assistance might be d...
: Development assistance for health (DAH) is one of the most important means for Japan to promote
diplomacy with developing countries and contribute to the international community. This study, for the first time,
estimated the gross disbursement of Japan’s DAH from 2012 to 2016 and clarified its...
Development assistance for health (DAH) is an important part of financing healthcare in low- and middle-income countries. We estimated the gross disbursement of DAH of the 29 Development Assistance Committee (DAC) member countries of the Organisation for Economic Co-operation and Development (OECD) ...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
This article analyzes the impact of the COVID-19 pandemic on foreign aid. Using examples from Canadian foreign aid, it argues that, despite the terrible toll it is exacting, the crisis has accelerated some significant positive pre-existing trends, both by destabilizing the perception of aid as flowi...
The annual Development Co-operation Report brings new evidence, analysis and ideas on
sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Cholera is an acute gastrointestinal infection caused by the bacterium Vibrio Cholerae serogroup O1 or O139, and is often linked to unsafe drinking water, lack of proper sanitation and personal hygiene. It adversely affects mostly the poor and vulnerable populations in countries, which are already d...
In 2024, we need US$1.5 billion to provide live-saving health care to millions of people in emergencies. An alarming combination of conflict, climate-related threats and increasing economic hardship mean an estimated 166 million people require health assistance.
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in the global effort to achieve and maintain a polio free world. However, fragmented approaches and short-term planning pose considera...
